StonvexLoading…
StonvexStonvexStonvexCore line items from ASRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.93M | $118.71M | $105.17M | $55.71M |
Operating Income | $-18.47M | $-21.54M | $-9.79M | $-21.27M |
Net Income | $-18.86M | $-30.38M | $-18.45M | $-29.89M |
EPS (Diluted) | $-2.93 | $-4.74 | $-0.19 | $-0.31 |
Total Assets | $211.30M | $266.97M | $319.77M | $273.78M |
Total Liabilities | $135.67M | $173.02M | $213.97M | $180.48M |
Cash & Equivalents | $33.71M | $10.23M | $38.50M | $47.09M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 6.45M | 6.42M | 96.25M | 96.22M |